论文部分内容阅读
目的探讨氨溴索不同给药途径对支气管肺炎的治疗效果。方法选择2008年1月至2009年5月收治的100例支气管肺炎患儿,以奇偶数法随机分为观察组50例和对照组50例。在综合治疗的基础上,观察组采用氧驱动雾化吸入氨溴索治疗,对照组采用静脉滴注氨溴索治疗,比较2组疗效和症状改善时间。结果观察组治愈率94.0%,对照组治愈率80.0%,观察组优于对照组(P<0.05)。热退时间、咳嗽消失时间、喘息消失时间、肺部罗音消失时间及住院天数观察组均短于对照组(P均<0.05)。结论氨溴索氧驱动雾化吸入治疗支气管肺炎疗效优于静脉滴注法治疗。
Objective To investigate the therapeutic effect of ambroxol on bronchopneumonia by different route of administration. Methods A total of 100 cases of bronchial pneumonia admitted from January 2008 to May 2009 were randomly divided into observation group (50 cases) and control group (50 cases). On the basis of comprehensive treatment, the observation group was treated with inhalation of ambroxol by oxygenated inhalation, and the control group was treated by intravenous infusion of ambroxol. The curative effect and symptom improvement time were compared between the two groups. Results The cure rate of the observation group was 94.0%, the cure rate of the control group was 80.0%, the observation group was superior to the control group (P <0.05). The time of fever, the disappearance of cough, the disappearance of wheezing, the disappearance of pulmonary rales and the days of hospitalization in observation group were shorter than those in control group (all P <0.05). Conclusion Ambroxol inhalation aerosol inhalation treatment of bronchial pneumonia is superior to intravenous drip therapy.